Scientists discovered a shorter version of the humanin peptide (AGA-(C8R)HNG17) that is about 100 times more potent than the original. In water it forms a beta‑sheet shape, but in dilute buffer it becomes disordered like the original peptide. It stays as single molecules (monomeric) in buffer, while the older version tends to clump together, which likely explains its higher activity.
Kariya. Shingo S; Hirano. Makito M; Furiya. Yoshiko Y; Ueno. Satoshi S
Humanin is a tiny protein that can raise the energy (ATP) inside cells and protect them from dying, even in cells that have a common mitochondrial mutation linked to MELAS, and it does this without causing extra mitochondrial DNA replication that could increase stress.
The study used computer simulations to see how the tiny brain‑protective peptide Humanin behaves in water versus a water‑plus‑TFE mix. In plain water the peptide is floppy and partly unfolded, while the TFE mixture forces it into a stable helix shape that may help it cross cell membranes or bind receptors.
The study shows that a modified version of the peptide humanin (called S14G‑humanin or HNG) can protect mouse brain cells from the harmful effects of a piece of amyloid‑beta, which is linked to early Alzheimer’s changes. In brain slices, HNG helped restore the normal strengthening of connections (LTP) that amyloid‑beta normally blocks, and it also brought back a key signaling protein (phosphorylated CREB). This suggests HNG might help keep brain communication healthy in the early stages of Alzheimer’s, but the work is still in mouse tissue, not people.
Humanin is a tiny 24‑amino‑acid peptide that can protect brain cells, but in plain water it’s mostly floppy and only forms small turns. When placed in a slightly less watery environment (30% TFE), it folds into a stable helix that might be needed for it to bind receptors or cross cell membranes. This structural flexibility hints that how you deliver or formulate humanin could affect its activity.
Chiba. Tomohiro T; Yamada. Marina M; Hashimoto. Yuichi Y; Sato. Maiko M; Sasabe. Jumpei J; Kita. Yos...
Scientists made a new peptide called colivelin by attaching a brain‑growth factor to a stronger version of humanin. In mouse studies it stopped brain‑cell death and memory loss caused by Alzheimer‑related proteins at unbelievably low doses (100 femtomolar) and even worked when injected into the body, meaning it can cross the blood‑brain barrier. This shows that boosting humanin activity could be a powerful way to protect the brain, but it’s still early‑stage animal work and not ready for personal use yet.
Scientists mapped the shape of a modified humanin peptide (S14G‑humanin) that is about 1,000 times stronger at protecting brain cells from Alzheimer‑related damage. In water the peptide is flexible, while in a more oily setting it forms a helix, and this flexibility may help it interact with its targets.
Chiba. Tomohiro T; Yamada. Marina M; Aiso. Sadakazu S
Humanin is a small protein that can protect brain cells from the damage caused by amyloid‑beta, a key player in Alzheimer’s disease. It does this by turning on the JAK2/STAT3 signaling pathway, which keeps neurons healthy. As we age or develop disease, this pathway weakens, leading to memory problems, but boosting it with humanin or its stronger version, colivelin, may help preserve brain function.
Humanin is a small natural peptide that can block a specific cell‑death protein called BimEL, helping cells survive harmful stress. This adds to its known ability to inhibit another death protein, Bax, showing it works through multiple anti‑apoptotic pathways.
A study found that giving the peptide Colivelin (a humanin‑like molecule) through the nose lets it reach the brain and improves memory problems in mouse models of Alzheimer’s disease. The benefit seems linked to activating a brain protein called STAT3 and protecting nerve cells that use acetylcholine, a key brain chemical for learning.
Niikura. Takako T; Yamada. Marina M; Chiba. Tomohiro T; Aiso. Sadakazu S; Matsuoka. Masaaki M; Nishi...
A study found that a mutant form of the protein that leads to Alzheimer's kills brain cells, but the tiny peptide humanin can protect those cells in a lab dish. This suggests humanin might help guard neurons against certain stress pathways linked to Alzheimer’s, though the work is still early and done in cells, not people.
A lab-made peptide called Colivelin, which includes a piece of the humanin protein, helped mice that model ALS live longer and move better, but this was only shown in mice and used direct brain injections, so it’s not something you can try now.
The study shows that the protein humanin can protect brain cells from the toxic effects of Alzheimer’s‑related amyloid‑beta by blocking a specific cell‑death pathway, but the work was done in lab‑grown cells, not people.
Chiba. T T; Yamada. M M; Sasabe. J J; Terashita. K K; Shimoda. M M; Matsuoka. M M; Aiso. S S
The study shows that a peptide related to humanin can reverse memory problems in an Alzheimer’s mouse model by re‑activating a brain signaling pathway (JAK2/STAT3) that amyloid‑beta normally suppresses. This suggests the pathway is a key link between amyloid toxicity and memory loss, and that boosting it with humanin‑like compounds might protect cognition.
The study shows that the peptide humanin can protect nerve cells in a dish from the toxic effects of Alzheimer's‑related amyloid‑beta by blocking two different death pathways that involve the p75 neurotrophin receptor. This suggests humanin has neuroprotective potential, but the work is still early‑stage and done only in cell cultures.
The study shows that a protein fragment from the Alzheimer's precursor can cause brain cells to die, but a small peptide called humanin can stop this cell death in lab experiments. This suggests humanin might protect neurons from certain Alzheimer‑related damage, though the work is still at the cell‑culture stage.
The study shows that a small protein called Humanin can protect brain cells from dying when they’re exposed to harmful versions of a gene linked to early‑onset Alzheimer’s. It works against two different toxic pathways caused by mutations in different parts of the gene, suggesting Humanin has broad neuroprotective potential.
Guo. Bin B; Zhai. Dayong D; Cabezas. Edelmira E; Welsh. Kate K; Nouraini. Shahrzad S; Satterthwait....
The study shows that the tiny protein humanin can stick to a cell‑death trigger called Bax and stop it from moving to the mitochondria, which blocks the cascade that leads to cell death. When humanin levels are lowered, cells become more vulnerable to Bax‑driven death. Both the nuclear‑encoded and mitochondrial‑encoded versions of humanin work the same way.
The study found that a protein called TRIM11 binds to the neuroprotective peptide Humanin and marks it for destruction inside cells, lowering Humanin’s levels. This means the body naturally regulates Humanin, and interfering with TRIM11 could keep more Humanin around, potentially boosting its brain‑protective effects.
This study shows that a protein called APP can kill brain cells through a signaling pathway involving JNK, and that the tiny peptide Humanin can block this cell death, suggesting it might help protect neurons in conditions like Alzheimer’s, though the work was done in cells, not people.